Generation and characterization of rat anti-mouse ST2L monoclonal antibodies

Hybridoma

Volumn 30, Issue 2, 2011, Pages 153-162

  Fursov, Natalie ^a   Johnston, Erin ^b   Duffy, Karen ^b   Cotty, Adam ^a   Petley, Theodore ^a   Fisher, Jamie ^a   Jiang, Haiyan ^a   Rycyzyn, Michael A ^a   Giles Komar, Jill ^a   Powers, Gordon ^a  

^a CENTOCOR INC   (United States)

^b Centocor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; INTERLEUKIN 33; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ST2L; RECOMBINANT PROTEIN; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOTIN; CELL PROLIFERATION; DOWN-REGULATION; HEK293 CELLS; HUMANS; HYBRIDOMAS; HYPERSENSITIVITY; IMMUNOCONJUGATES; INFLAMMATION; INTERLEUKIN-1; INTERLEUKINS; MICE; MICE, INBRED BALB C; NF-KAPPA B; PLASMIDS; RATS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TH2 CELLS; TRANSFECTION;

ANIMALIA; RATTUS;

EID: 79955635517     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0100     Document Type: Article

References (19)

1. Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, and Tominaga S: Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 1993;318:83-87. (Pubitemid 23057042)
2. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, Piedrafita D, Robinson JH, and Liew FY: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787-794. (Pubitemid 28115194)
3. Löhning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC, Levinson D, Radbruch A, and Kamradt T: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998;95:6930-6935. (Pubitemid 28278084)
4. Moritz DR, Rodewald HR, Gheyselinck J, and Klemenz R: The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 1998;161:4866-4874. (Pubitemid 28492065)
5. Schneider E, Petit-Bertron AF, Bricard R, Levasseur M, Ramadan A, Girard JP, Herbelin A, and Dy M: IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol 2009;183:3591-3597.
6. Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A, Nakae S, Matsushima K, Ohta K, Yamamoto K, and Yamaguchi M: An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008;181:5981-5989.
7. Kumar S, Tzimas MN, Griswold DE, and Young PR: Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 1997;235:474-478. (Pubitemid 27326503)
8. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, and Kastelein RA: IL-33, an interleukin- 1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-490. (Pubitemid 41587888)
9. Coyle AJ, Lloyd C, Tian J, Nguyen T, Erikkson C, Wang L, Ottoson P, Persson P, Delaney T, Lehar S, Lin S, Poisson L, Meisel C, Kamradt T, Bjerke T, Levinson D, and Gutierrez- Ramos JC: Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999;190:895-902. (Pubitemid 29480818)
10. Walzl G, Matthews S, Kendall S, Gutierrez-Ramos JC, Coyle AJ, Openshaw PJ, and Hussell T: Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med 2001;193:785-792. (Pubitemid 32524528)
11. Leung BP, Xu D, Culshaw S, McInnes IB, and Liew FY: A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 2004;173:145-150. (Pubitemid 38797335)
12. Kearley J, Buckland KF, Mathie SA, and Lloyd CM: Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009;179:772-781.
13. Rahul Kakkar R, and Lee RT: The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7:827-840.
14. Li H, Tago K, Io K, Kuroiwa K, Arai T, Iwahana H, Tominaga S, and Yanagisawa K: The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000;67: 284-290. (Pubitemid 30651029)
15. Tominaga A, Mita S, Kikuchi Y, Hitoshi Y, Takatsu K, Nishikawa S, and Ogawa M: Establishment of IL-5- dependent early B cell lines by long-term bone marrow cultures. Growth Factors 1989;1:135-146.
16. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, and Martin MU: IL-1 receptor accessory protein is essential for IL-33- induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007;104:18660-18665. (Pubitemid 350210753)
17. Hayakawa H, Hayakawa M, Kume A, and Tominaga S: Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282:26369-26380. (Pubitemid 47443815)
18. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, Niedbala W, McKenzie AN, Teixeira MM, Liew FY, and Xu D: IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008;181:4780-4790.
19. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie AN, McInnes IB, and Liew FY: IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008;105:10913-10918.